Results 281 to 290 of about 1,292,062 (304)

Activators, deactivators and deactivated activators

Current Biology, 1992
openaire   +2 more sources

A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary Angioplasty

New England Journal of Medicine, 1987
Eric J Topol, Myron L Weisfeldt
exaly  

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

Lancet, The, 2011
John R Teerlink, Chim C Lang
exaly  

Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year

New England Journal of Medicine, 1999
Thomas G Kwiatkowski
exaly  

Activation energy, activation enthalpy, activation volume

2006
openaire   +1 more source

Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial Infarction

New England Journal of Medicine, 1984
exaly  

Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial Infarction

New England Journal of Medicine, 1995
Daniel B Mark, Mark A Hlatky, Paul W Armstrong   +2 more
exaly  

PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION

Lancet, The, 1987
exaly  

4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease

Lancet, The, 1999
Jan A Hazelzet, Michael Levin
exaly  

Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction

New England Journal of Medicine, 1989
exaly